Company Filing History:
Years Active: 2021-2022
Title: Paul D O'Shea: Innovator in Imidazo[1,2-a]pyrimidine Synthesis
Introduction
Paul D O'Shea is a notable inventor based in Princeton, NJ (US), recognized for his contributions to the field of organic chemistry. He holds 2 patents that focus on the synthesis of imidazo[1,2-a]pyrimidines, which are significant in the development of tracer molecules for neurological studies.
Latest Patents
His latest patents include methods for regio-selective synthesis of imidazo[1,2-a]pyrimidines. This innovative method involves coupling specific compounds to produce either 2-amino or 4-amino constitutional isomers with high yields and regio-selectivity. The synthesis of labeled imidazo[1,2-a]pyrimidines is another significant patent, which allows for the production of isotopically substituted molecules with over 95% purity.
Career Highlights
Paul D O'Shea is currently employed at Genentech, Inc., where he applies his expertise in organic synthesis to advance research in neurological conditions. His work has contributed to the development of new compounds that can aid in the understanding and treatment of various neurological disorders.
Collaborations
He collaborates with talented colleagues such as Kyle Bradley, Pascual Clagg, and Nicholas Andrew White, enhancing the innovative environment at Genentech, Inc. Their combined efforts in research and development have led to significant advancements in their field.
Conclusion
Paul D O'Shea's work in the synthesis of imidazo[1,2-a]pyrimidines showcases his innovative spirit and dedication to advancing organic chemistry. His contributions are vital for the development of new therapeutic agents in the study of neurological conditions.